Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity

References

• Bernstein M, Kovar H, Paulussen M, Randall RL, Schuck A, Teot LA, Juergens H. Ewing's sarcoma family of tumors: current management. Oncologist 2006; 11:503-19; PMID:16720851; http://dx.doi.org/10.1634/theoncologist.11-5-503
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C, Navid F, Liu T, Billups CA, Rao BN, Krasin MJ. Prognostic factors for local and distant control in Ewing sarcoma family of tumors. Ann Oncol 2008; 19:814-20; PMID:17998282; http://dx.doi.org/10.1093/annonc/mdm521
   PubMed Web of Science ®Google Scholar
• Burdach S, Jurgens H. High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT). Crit Rev Oncol Hematol 2002; 41:169-89; PMID:11856593; http://dx.doi.org/10.1016/S1040-8428(01)00154-8
   PubMed Web of Science ®Google Scholar
• Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343:750-8; PMID:10984562; http://dx.doi.org/10.1056/NEJM200009143431101
   PubMed Web of Science ®Google Scholar
• Cieri N, Mastaglio S, Oliveira G, Casucci M, Bondanza A, Bonini C. Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation. Immunol Rev 2014; 257:165-80; PMID:24329796; http://dx.doi.org/10.1111/imr.12130
   PubMed Web of Science ®Google Scholar
• Burdach S, Thiel U, Schoniger M, Haase R, Wawer A, Nathrath M, Kabisch H, Urban C, Laws HJ, Dirksen U et al. Total body MRI-governed involved compartment irradiation combined with high-dose chemotherapy and stem cell rescue improves long-term survival in Ewing tumor patients with multiple primary bone metastases. Bone Marrow Transplant 2010 Mar; 45(3):483-9; PMID:19684633; http://dx.doi.org/doi:10.1038/bmt.2009.184
   PubMed Web of Science ®Google Scholar
• Koscielniak E, Gross-Wieltsch U, Treuner J, Winkler P, Klingebiel T, Lang P, Bader P, Niethammer D, Handgretinger R. Graft-versus-Ewing sarcoma effect and long-term remission induced by haploidentical stem-cell transplantation in a patient with relapse of metastatic disease. J Clin Oncol 2005; 23:242-4; PMID:15625381; http://dx.doi.org/10.1200/JCO.2005.05.940
   PubMed Web of Science ®Google Scholar
• Lucas KG, Schwartz C, Kaplan J. Allogeneic stem cell transplantation in a patient with relapsed Ewing sarcoma. Pediatr Blood Cancer 2008; 51:142-4; PMID:18266223; http://dx.doi.org/10.1002/pbc.21503
   PubMed Web of Science ®Google Scholar
• Storb R, Gyurkocza B, Storer BE, Sorror ML, Blume K, Niederwieser D, Chauncey TR, Pulsipher MA, Petersen FB, Sahebi F et al. Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation. J Clin Oncol 2013; 31:1530-8; PMID:23478054; http://dx.doi.org/10.1200/JCO.2012.45.0247
   PubMed Web of Science ®Google Scholar
• Burdach S, van Kaick B, Laws HJ, Ahrens S, Haase R, Korholz D, Pape H, Dunst J, Kahn T, Willers R et al. Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-cell transplant programs at Dusseldorf University Medical Center, Germany and St. Anna Kinderspital, Vienna, Austria. Ann Oncol 2000; 11:1451-62; PMID:11142486; http://dx.doi.org/10.1023/A:1026539908115
   PubMed Web of Science ®Google Scholar
• Moris A, Teichgraber V, Gauthier L, Buhring HJ, Rammensee HG. Cutting edge: characterization of allorestricted and peptide-selective alloreactive T cells using HLA-tetramer selection. J Immunol 2001; 166:4818-21; PMID:11290755; http://dx.doi.org/10.4049/jimmunol.166.8.4818
   PubMed Web of Science ®Google Scholar
• Schuster IG, Busch DH, Eppinger E, Kremmer E, Milosevic S, Hennard C, Kuttler C, Ellwart JW, Frankenberger B, Nössner E et al. Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies. Blood 2007; 110:2931-9; PMID:17626842; http://dx.doi.org/10.1182/blood-2006-11-058750
   PubMed Web of Science ®Google Scholar
• Thiel U, Pirson S, Muller-Spahn C, Conrad H, Busch DH, Bernhard H, Richter GH. Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells. Br J Cancer 2011; 104:948-56; PMID:21407224; http://dx.doi.org/10.1038/bjc.2011.54
   PubMed Web of Science ®Google Scholar
• June CH, Riddell SR, Schumacher TN. Adoptive cellular therapy: a race to the finish line. Sci Transl Med 2015 Oct;149(4):1042-52; PMID:25810311; http://dx.doi.org/10.1053/j.gastro.2015.05.055
   PubMed Web of Science ®Google Scholar
• Dargel C, Bassani-Sternberg M, Hasreiter J, Zani F, Bockmann JH, Thiele F, Bohne F, Wisskirchen K, Wilde S, Sprinzl MF et al. T cells engineered to express a T-cell receptor specific for Glypican-3 to recognize and kill hepatoma cells in vitro and in mice. Gastroenterology 2015; 149(4):1042-52; PMID:26052074; http://dx.doi.org/10.1053/j.gastro.2015.05.055
   PubMed Web of Science ®Google Scholar
• Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol 2011; 29:917-24; PMID:21282551; http://dx.doi.org/10.1200/JCO.2010.32.2537
   PubMed Web of Science ®Google Scholar
• Rosenberg SA, Restifo NP. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 2015; 348:62-8; PMID:25838374; http://dx.doi.org/10.1126/science.aaa4967
   PubMed Web of Science ®Google Scholar
• Staege MS, Hutter C, Neumann I, Foja S, Hattenhorst UE, Hansen G, Afar D, Burdach SE. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 2004; 64:8213-21; PMID:15548687; http://dx.doi.org/10.1158/0008-5472.CAN-03-4059
   PubMed Web of Science ®Google Scholar
• Grunewald TG, Diebold I, Esposito I, Plehm S, Hauer K, Thiel U, da Silva-Buttkus P, Neff F, Unland R, Müller-Tidow C et al. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors. Mol Cancer Res 2012; 10:52-65; PMID:22080479; http://dx.doi.org/10.1158/1541-7786.MCR-11-0524
   PubMed Web of Science ®Google Scholar
• Ohgami RS, Campagna DR, McDonald A, Fleming MD. The Steap proteins are metalloreductases. Blood 2006; 108:1388-94; PMID:16609065; http://dx.doi.org/10.1182/blood-2006-02-003681
   PubMed Web of Science ®Google Scholar
• Sommermeyer D, Uckert W. Minimal amino acid exchange in human TCR constant regions fosters improved function of TCR gene-modified T cells. J Immunol 2010; 184:6223-31; PMID:20483785; http://dx.doi.org/10.4049/jimmunol.0902055
   PubMed Web of Science ®Google Scholar
• Cieri N, Camisa B, Cocchiarella F, Forcato M, Oliveira G, Provasi E, Bondanza A, Bordignon C, Peccatori J, Ciceri F et al. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors. Blood 2013; 121:573-84; PMID:23160470; http://dx.doi.org/10.1182/blood-2012-05-431718
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Fukushi J, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, Yamada H, Okada S, Watari K, Ono M et al. Macrophage infiltration predicts a poor prognosis for human Ewing sarcoma. Am J Pathol 2011; 179:1157-70; PMID:21771572; http://dx.doi.org/10.1016/j.ajpath.2011.05.034
   PubMed Web of Science ®Google Scholar
• Brinkrolf P, Landmeier S, Altvater B, Chen C, Pscherer S, Rosemann A, Ranft A, Dirksen U, Juergens H, Rossig C. A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease. Int J Cancer 2009; 125:879-86; PMID:19480009; http://dx.doi.org/10.1002/ijc.24461
   PubMed Web of Science ®Google Scholar
• Brohl AS, Solomon DA, Chang W, Wang J, Song Y, Sindiri S, Patidar R, Hurd L, Chen L, Shern JF et al. The genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation. PLoS Genet 2014; 10:e1004475; PMID:25010205; http://dx.doi.org/10.1371/journal.pgen.1004475
   PubMed Web of Science ®Google Scholar
• Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA, Mehta SS et al. The genomic landscape of pediatric Ewing sarcoma. Cancer Discov 2014; 4:1326-41; PMID:25186949; http://dx.doi.org/10.1158/2159-8290.CD-13-1037
   PubMed Web of Science ®Google Scholar
• Tirode F, Surdez D, Ma X, Parker M, Le Deley MC, Bahrami A, Zhang Z, Lapouble E, Grossetête-Lalami S, Rusch M et al. Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov 2014; 4:1342-53; PMID:25223734; http://dx.doi.org/10.1158/2159-8290.CD-14-0622
   PubMed Web of Science ®Google Scholar
• Agelopoulos K, Richter GH, Schmidt E, Dirksen U, von Heyking K, Moser B, Klein HU, Kontny U, Dugas M, Poos K et al. Deep sequencing in conjunction with expression and functional analyses reveals activation of FGFR1 in Ewing sarcoma. Clin Cancer Res 2015; 21(21):4935-46; PMID:26179511; http://dx.doi.org/10.1158/1078-0432.CCR-14-2744
   PubMed Web of Science ®Google Scholar
• Mackall CL, Rhee EH, Read EJ, Khuu HM, Leitman SF, Bernstein D, Tesso M, Long LM, Grindler D, Merino M et al. A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas. Clin Cancer Res 2008; 14:4850-8; PMID:18676758; http://dx.doi.org/10.1158/1078-0432.CCR-07-4065
   PubMed Web of Science ®Google Scholar
• Lessnick SL, Ladanyi M. Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets. Ann Rev Path 2012; 7:145-59; PMID:21942527; http://dx.doi.org/10.1146/annurev-pathol-011110-130237
   PubMed Web of Science ®Google Scholar
• Mackintosh C, Madoz-Gúrpide J, Ordóñez JL, Osuna D, Herrero-Martín D. The molecular pathogenesis of Ewing's sarcoma. Cancer Biol Therapy 2010; 9:655-67; PMID:20215864; http://dx.doi.org/10.4161/cbt.9.9.11511
   PubMed Web of Science ®Google Scholar
• Kovar H. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy. Expert Opin Ther Targets 2014; 18:1315-28; PMID:25162919; http://dx.doi.org/10.1517/14728222.2014.947963
   PubMed Web of Science ®Google Scholar
• Meyer-Wentrup F, Richter G, Burdach S. Identification of an immunogenic EWS-FLI1-derived HLA-DR-restricted T helper cell epitope. Pediatr Hematol Oncol 2005; 22:297-308; PMID:16020117; http://dx.doi.org/10.1080/08880010590935194
   PubMed Web of Science ®Google Scholar
• Evans CH, Liu F, Porter RM, O'Sullivan RP, Merghoub T, Lunsford EP, Robichaud K, Van Valen F, Lessnick SL, Gebhardt MC et al. EWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumors. Clin Cancer Res 2012; 18:5341-51; PMID:22879388; http://dx.doi.org/10.1158/1078-0432.CCR-12-1985
   PubMed Web of Science ®Google Scholar
• Grunewald TG, Ranft A, Esposito I, da Silva-Buttkus P, Aichler M, Baumhoer D, Schaefer KL, Ottaviano L, Poremba C, Jundt G et al. High STEAP1 expression is associated with improved outcome of Ewing's sarcoma patients. Ann Oncol 2012; 23:2185-90; PMID:22317770; http://dx.doi.org/10.1093/annonc/mdr605
   PubMed Web of Science ®Google Scholar
• Grunewald TG, Bach H, Cossarizza A, Matsumoto I. The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions. Biol Cell 2012; 104:641-57; PMID:22804687; http://dx.doi.org/10.1111/boc.201200027
   PubMed Web of Science ®Google Scholar
• Burdach S, Meyer-Bahlburg A, Laws HJ, Haase R, van Kaik B, Metzner B, Wawer A, Finke R, Göbel U, Haerting J et al. High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiation. J Clin Oncol 2003; 21:3072-8; PMID:12915596; http://dx.doi.org/10.1200/JCO.2003.12.039
   PubMed Web of Science ®Google Scholar
• Burdach S. Treatment of advanced Ewing tumors by combined radiochemotherapy and engineered cellular transplants. Pediatr Transplant 2004; 8:67-82; PMID:15125708; http://dx.doi.org/10.1111/j.1398-2265.2004.00186.x
   PubMed Web of Science ®Google Scholar
• Burdach S, Jurgens H, Peters C, Nurnberger W, Mauz-Korholz C, Korholz D, Paulussen M, Pape H, Dilloo D, Koscielniak E et al. Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma. J Clin Oncol 1993; 11:1482-8; PMID:8101562
   PubMed Web of Science ®Google Scholar
• Meyers PA, Krailo MD, Ladanyi M, Chan KW, Sailer SL, Dickman PS, Baker DL, Davis JH, Gerbing RB, Grovas A et al. High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis. J Clin Oncol 2001; 19:2812-20; PMID:11387352
   PubMed Web of Science ®Google Scholar
• Cotterill SJ, Ahrens S, Paulussen M, Jurgens HF, Voute PA, Gadner H, Craft AW. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000; 18:3108-14; PMID:10963639
   PubMed Web of Science ®Google Scholar
• Thiel U, Wawer A, Wolf P, Badoglio M, Santucci A, Klingebiel T, Basu O, Borkhardt A, Laws HJ, Kodera Y et al. No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patients. Ann Oncol 2011; 22:1614-21; PMID:21245159; http://dx.doi.org/10.1093/annonc/mdq703
   PubMed Web of Science ®Google Scholar
• Felix NJ, Allen PM. Specificity of T-cell alloreactivity. Nat Rev Immunol 2007; 7:942-53; PMID:18007679; http://dx.doi.org/10.1038/nri2200
   PubMed Web of Science ®Google Scholar
• Burdach S, Kolb HJ. The vigor of defense against non-self: potential superiority of allorestricted T cells in immunotherapy of cancer?. Front Oncol 2013; 3:100; PMID:23653891; http://dx.doi.org/10.3389/fonc.2013.00100
   PubMedGoogle Scholar
• Thiel U, Wolf P, Wawer A, Blaeschke F, Grunewald TG, von Luttichau IT, Klingebiel T, Bader P, Borkhardt A, Laws HJ et al. Human leukocyte antigen distribution in German Caucasians with advanced Ewing's sarcoma. Klin Padiatr 2012; 224:353-8; PMID:22821288; http://dx.doi.org/10.1055/s-0032-1321730
   PubMed Web of Science ®Google Scholar
• Cohen CJ, Zhao Y, Zheng Z, Rosenberg SA, Morgan RA. Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability. Cancer Res 2006; 66:8878-86; PMID:16951205; http://dx.doi.org/10.1158/0008-5472.CAN-06-1450
   PubMed Web of Science ®Google Scholar
• Fast LD, DiLeone G, Cardarelli G, Li J, Goodrich R. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice. Transfusion 2006; 46:1553-60; PMID:16965583; http://dx.doi.org/10.1111/j.1537-2995.2006.00939.x
   PubMed Web of Science ®Google Scholar
• Turtle CJ, Riddell SR. Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy. Curr Opin Immunol 2011; 23:299-305; PMID:21237630; http://dx.doi.org/10.1016/j.coi.2010.12.012
   PubMed Web of Science ®Google Scholar
• Hinrichs CS, Borman ZA, Cassard L, Gattinoni L, Spolski R, Yu Z, Sanchez-Perez L, Muranski P, Kern SJ, Logun C et al. Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity. Proc Natl Acad Sci USA 2009; 106:17469-74; PMID:19805141; http://dx.doi.org/10.1073/pnas.0907448106
   PubMed Web of Science ®Google Scholar
• Stemberger C, Huster KM, Koffler M, Anderl F, Schiemann M, Wagner H, Busch DH. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity 2007; 27:985-97; PMID:18082432; http://dx.doi.org/10.1016/j.immuni.2007.10.012
   PubMed Web of Science ®Google Scholar
• Busch DH, Pilip IM, Vijh S, Pamer EG. Coordinate regulation of complex T cell populations responding to bacterial infection. Immunity 1998; 8:353-62; PMID:9529152; http://dx.doi.org/10.1016/S1074-7613(00)80540-3
   PubMed Web of Science ®Google Scholar